The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.

Yao-Min HungLichi LinChyong-Mei ChenJeng-Yuan ChiouYu-Hsun WangPaul Yung-Pou WangJames Cheng-Chung Wei

Published in: PloS one (2017)

This study revealed association of decreased CAD risk in RA patients taking 2 different kinds of COX-2i in comparison with nonusers. The effect might be changed over time, after about 4 years.

Keyphrases

coronary artery
end stage renal disease
rheumatoid arthritis
newly diagnosed
chronic kidney disease
coronary artery disease
peritoneal dialysis
single cell
breast cancer risk